CLINICAL TRIAL INVESTIGATIVE SITES

 

 

The DELTA HEALTH GROUP operates its own global network of dedicated and strategically located clinical trial investigative sites based on the maxim.....EXPERIENCE.....INTEGRITY....QUALITY.

 

We have long-term exclusivity agreements with globally located prominent teaching hospitals and clinics to operate and manage state-of-the-art clinical investigative sites having extensive experience in conducting drug development clinical trials according to ICH Good Clinical Practice Guidelines.

 

A number of these high-performance international investigative sites covering a multi-ethnic catchment area population of 10 million plus, have preferred access to a fast growing, highly compliant local clinical trial subject populace. 

 

Independently audited and qualified, a number of these clinical facilities are recipients of the prestigious "Best Clinical Trial Site" recognition. These international investigative sites, primarily focused on conducting Phase 1, Phase 2 and Phase 3 drug development clinical trials have very low screen-failure and excellent patient retention rates. These clinical facilities are directly operated and managed by the DELTA HEALTH team members who have in-depth knowledge and hands-on experience in the management of successful North American clinical trial investigative sites.